Capital Cell
Life sciences and biotech equity crowdfunding. Early-stage healthcare innovation investments.
General Information
Capital Cell is an FCA-authorised life sciences and biotech equity crowdfunding platform founded in 2014 with approximately €35 million invested. The platform specialises in early-stage healthcare innovation across the UK and Europe.
How does it work?
The platform sources and evaluates early-stage life sciences companies with team members from scientific backgrounds. Companies are assessed on science, intellectual property, regulatory pathway, and commercial potential.
What do they offer?
Equity investments in life sciences startups from approximately €1,000 across biotech, medtech, and digital health. No secondary market. Life sciences investments have long timelines and binary clinical outcomes.
Who is it for?
Suited to investors with interest in life sciences. Clinical trials can fail, regulatory approval can be denied. Total capital loss is realistic. Diversification is essential.
Unlock full platform information
- How does it work?
- What do they offer?
- Who is it for?
Already a member?
Free forever · No spam · Takes 10 seconds
Disclaimer: This article is for informational and educational purposes only and does not constitute financial advice and should not be considered as such. In particular, it does not constitute personal advice — please consult a qualified financial adviser to address your particular personal requirements. Other is not regulated by the Financial Conduct Authority (FCA), its authors are not financial advisers and it is therefore not authorised to offer financial advice. This article is not intended as an offer, invitation or solicitation for the purchase or sale of any investment, nor is its issuance intended to give rise to any other legal relations whatsoever and must not be relied upon for the purposes of any investment decision. The information contained in this article is subject to updating, revision and amendment.
Recommended Guides
Related Platforms
Unlock the full Capital Cell profile